Every finding on record at La Care Hospice Inc.

Upon patient record review, 1 of 14 (Patient #3) did not have evidence in the patient record that a review was completed of all prescription and non-prescription medications, including herbal remedies that could affect drug therapy. This review includes, but is not limited to: • Effectiveness of drug therapy • Drug side effects • Actual or potential drug interactions • Duplicate drug therapy • Drug therapy currently associated with laboratory monitoring Patient #3: The medication profile indicated two entries of the same medication (Trade/Generic) as follows: Escitalopram 10mg QD and Lexapro 10mg QD. Corrected on site- Agency updated medication list.

Upon patient record review, 1 of 14 (Patient #3) did not have evidence the plan of care must include all services necessary for the palliation and management of the terminal illness and related conditions, including medications and treatments. Patient #3: The plan of care indicated two entries of the same medication (Trade/Generic) as follows: Escitalopram 10mg QD and Lexapro 10mg QD. Corrected on site- Agency updated plan of care summary.

Upon personnel record review, 1 of 12 (Personnel #8 ) did not have evidence in the personnel file that the following competency assessment was performed by the aide with a patient: ·Reading and recording temperature (auxiliary, rectal and tympanic). These tasks were indicated as verbalized, not observed.

Upon contract review, 1 of 4 (PT/OT/ST contract) did not have evidence the agreement included all CMS requirements as follows: • Furnished in a safe and effective manner by qualified personnel

Upon client record review, 1 of 14 (Patient #11) did not have evidence that the discharge summary includes all required information, as follow: • The patient's current plan of care

Upon patient record review, 1 of 5 (Patient #3) did not have evidence in the patient record that a review was completed of all prescription and non-prescription medications, including herbal remedies that could affect drug therapy. This review includes, but is not limited to: • Effectiveness of drug therapy • Drug side effects • Actual or potential drug interactions • Duplicate drug therapy • Drug therapy currently associated with laboratory monitoring Patient #3 Upon med review during the home visit, the patient has Albuterol inhaler that is not included on the medication profile.

Upon patient record review, 1 of 5 (Patient #3) did not have evidence the plan of care must include all services necessary for the palliation and management of the terminal illness and related conditions, including medications and treatments. Patient #3 The plan of care does not include orders for the albuterol inhaler that was identified during the home visit.